This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Healthy Volunteer
and you are
between 18 and 45
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to assess the effects of oral TR-701 free acid (FA) versus placebo on QTcF.

Provided treatments

  • Drug: TR-701 FA 1200 mg
  • Drug: Moxifloxacin 400 mg
  • Drug: TR-701 FA 200 mg plus Placebo
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01461460. The sponsor of the trial is Trius Therapeutics LLC and it is looking for 48 volunteers for the current phase.
Official trial title:
A Phase 1 Blinded, Placebo-controlled Crossover Study to Evaluate the Effects of Oral TR 701 Free Acid on the Electrocardiogram